Until now there has been no large, thorough investigation into the risk of clean intermittent catheterization in patients undergoing repeat injections of onabotulinumtoxinA.
John Schieszer
Advertisement
Articles by John Schieszer
Advertisement
Advertisement
Advertisement
Trending on Urology Times
1
Ridwan I. Alam, MD, MPH, discusses combining PHI and MRI to predict prostate cancer risk
2
FDA grants 510(k) clearance to Break Wave lithotripsy device for kidney stones
3
ProFam-Risk registry aims to establish model for personalized prostate cancer prevention
4
Initial ARID results published in World Journal of Urology as pivotal trial progresses
5